pulmonary interstitial fibrosis
Conditions
Interventions
control group:placebo
Sponsors
Weihai Municipal Hospital Affiliated to Shandong University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Age: 18-75 years old; (2) Complies with FILD diagnostic criteria; (3) The condition is temporarily stable and medication can control the stage; (4) Informed and willing to participate in research and sign an informed
Exclusion criteria
Exclusion criteria: (1) Pregnant women or lactating patients; (2) Female patients who have not used any contraceptive measures; (3) Patients with unstable vital signs and unstable conditions; (4) Patients with concomitant other lung diseases; Such as acute lung infection, chronic obstructive pulmonary disease, bronchial asthma, pulmonary embolism, bronchiectasis, etc; (5) Combined with severe primary diseases such as active malignant tumors, stroke, and myocardial infarction; (6) Patients with a history of gastrointestinal diseases such as gastrointestinal bleeding, irritable bowel syndrome, Crohn's disease or ulcerative colitis, and a history of gastrointestinal surgery; (7) Patients with a history of mental illness; (8) Patients who have taken antibiotics, glucocorticoids or other immunosuppressive agents, foods or drugs containing probiotics or prebiotics within the past month; (9) Individuals who are allergic to the test sample or exhibit obvious gastrointestinal symptoms such as intolerance; (10) Simultaneously receiving other clinical trial patients; (11) Those who have been determined by the researcher to be unable to complete the research on time.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pulmonary function; | — |
Secondary
| Measure | Time frame |
|---|---|
| metabolic pathway; | — |
Countries
China
Contacts
Public ContactLiu Ailing
Weihai Municipal Hospital Affiliated to Shandong University
Outcome results
None listed